A patient (No. 2) whose primary tumor carried a TP53 missense mutation (TP53 Y220C) and a BRCA1 nonsense mutation (BRCA1 L63*) did not harbor germline BRCA1 pathogenic variants. This evidence concerns the gene BRCA1 and neoplasm.